About this trial
This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.
Eligibility criteria
Qualifiers
Individuals aged 20 years and above.
Participants residing in the randomized clusters of Karachi, Pakistan
Individuals willing to participate in the study and provide consent.
Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
Disqualifiers
Individuals below the age of 20 years.
Individuals unwilling to provide consent for participation.
Participants with severe health conditions that may hinder their active involvement in the study.
Individuals with non-compliance with research protocols
Trial design
Treatments tested in this trial
- Participatory, learning and Action (PLA) Based intervention
Treatment groups
Sponsors and collaborators
Baqai Institute of Diabetology and Endocrinology
Lead sponsor
University of York
Collaborator
Khyber Medical University Peshawar
Collaborator
HealthNet TPO
Collaborator
National Institute for Health Research, United Kingdom
Collaborator
Aga Khan University Hospital, Pakistan
Collaborator